Several studies have shown that SOCS proteins including SOCS3 are expressed in tumours including head and neck cancer [39,40], gastric carcinoma [41], chronic myeloid leukemia [42], melanoma [43] and prostate cancer [44,45]. This evidence concerns the gene SOCS3 and chronic myelogenous leukemia, BCR-ABL1 positive.